Evidence map›Paper›PMID 26424505›Full record

ArticleBMC infectious diseases2015

High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria.

Aimalohi A Ahonkhai, Bolanle Banigbe, Juliet Adeola, Ifeyinwa Onwuatuelo, Ingrid V Bassett, Elena Losina, Kenneth A Freedberg, Prosper Okonkwo, Susan Regan

Abstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The patient-centered medical home: a reality for HIV care in Nigeria.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2017
    Article
  12. Article
  13. Age Matters: Increased Risk of Inconsistent HIV Care and Viremia Among Adolescents and Young Adults on Antiretroviral Therapy in Nigeria.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2016
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Aimalohi A AhonkhaiDivision of Infectious Disease, Massachusetts General Hospital, 50 Staniford Street, 9th Floor, Boston, MA, USA. aahonkhai@mgh.harvard.edu.
Bolanle BanigbeAIDS Prevention Initiative in Nigeria (APIN), Abuja, Nigeria. baluko@apin.org.ng.
Juliet AdeolaAIDS Prevention Initiative in Nigeria (APIN), Abuja, Nigeria. jadeola@apin.org.ng.
Ifeyinwa OnwuatueloAIDS Prevention Initiative in Nigeria (APIN), Abuja, Nigeria. ionwuatuelo@apin.org.ng.
Ingrid V BassettDivision of Infectious Disease, Massachusetts General Hospital, 50 Staniford Street, 9th Floor, Boston, MA, USA. ibassett@mgh.harvard.edu.
Elena LosinaMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA. elosina@partners.org.
Kenneth A FreedbergDivision of Infectious Disease, Massachusetts General Hospital, 50 Staniford Street, 9th Floor, Boston, MA, USA. kfreedberg@mgh.harvard.edu.
Prosper OkonkwoAIDS Prevention Initiative in Nigeria (APIN), Abuja, Nigeria. pokonkwo@apin.org.ng.
Susan ReganMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA. sregan@mgh.harvard.edu.

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Optimizing HIV Care in Less Developed CountriesR01AI058736 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Kenneth Alan Freedberg, Emily Parker Hyle · 2004 to 2026
$21.5M
Linkage & Retention: A Randomized Trial to Optimize HIV/TB Care in South AfricaR01MH090326 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BASSETT, INGRID VALERIE · 2010 to 2014
$2.9M
Decreasing Interruptions and Losses from HIV Care in NigeriaK23AI106406 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AHONKHAI, AIMALOHI · 2013 to 2017
$914k
NCHHSTP CDC HHS U2G PS001058NIAID NIH HHS 2P30AI060354NIAID NIH HHS K23 AI106406NIAID NIH HHS K23 AI106406-02NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI058736NIAID NIH HHS R01 AI058736-09S1NIMH NIH HHS R01 MH090326PHS HHS 5U2GPS001058
6 · The paper itself

Abstract

backgroundUnplanned care interruption (UCI) challenges effective HIV treatment. We determined the frequency and risk factors for UCI in Nigeria.

methodsWe conducted a retrospective-cohort study of adults initiating antiretroviral therapy (ART) between January 2009 and December 2011. At censor, patients were defined as in care, UCI, or inactive. Associations between baseline factors and UCI rates were quantified using Poisson regression.

resultsAmong 2,496 patients, 44 % remained in care, 35 % had ≥1 UCI, and 21 % became inactive. UCI rates were higher in the first year on ART (39/100PY), than the second (19/100PY), third (16/100PY), and fourth (14/100PY) years (p < 0.001). In multivariate analysis, baseline CD4 > 350/uL (IRR 3.21, p < 0.0001), being a student (IRR 1.95, p < 0.0001), and less education (IRR 1.58, p = 0.001) increased risk for UCI. Fifty-five percent of patients with UCI and viral load data had HIV viral load > 1,000 copies/ml upon return to care. DISCUSSION: UCI were observed in over one-third of patients treated, and were most common in the first year on ART. High baseline CD4 count at ART initiation was the greatest predictor of subsequent UCI.

conclusionsInterventions focused on the first year on ART are needed to improve continuity of HIV care.

Indexed as

AdultAnti-HIV AgentsCD4 Lymphocyte CountCohort StudiesFemaleHIV-1HIV InfectionsHumansMaleMultivariate AnalysisNigeriaRetrospective StudiesRisk FactorsRNA, ViralTreatment OutcomeViral LoadAnti-HIV AgentsRNA, Viral

Identifiers

PMID26424505
PMCPMC4589963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.